Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice

Research in Veterinary Science

Volumn 96, Issue 3, 2014, Pages 551-557

  Mansoor, Fawad ^a   Earley, Bernadette ^b   Cassidy, Joseph P ^c   Markey, Bryan ^c   Foster, Colin ^a   Doherty, Simon ^a   Welsh, Michael D ^a  

^a AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^b ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Immunity; Nanoparticles; Parainfluenza virus type 3 (BPI3V); Respiratory disease; Vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NANOPARTICLE; POLYGLACTIN; VIRUS ANTIGEN; VIRUS PROTEIN; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG RELEASE; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARAINFLUENZA VIRUS 3; PARTICLE SIZE; PROTEIN MOTIF; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BOVINAE; CATTLE DISEASES; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; RANDOMIZATION; RESPIROVIRUS INFECTIONS; STANDARDS; VETERINARY; VIROLOGY;

ANIMALIA; BOVINE PARAINFLUENZA VIRUS 3; HUMAN PARAINFLUENZA VIRUS 3; MUS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, HUMORAL; LACTIC ACID; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARAINFLUENZA VIRUS 3, BOVINE; POLYGLYCOLIC ACID; RANDOM ALLOCATION; RESPIROVIRUS INFECTIONS; VIRAL VACCINES;

EID: 84899907322     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2014.03.002     Document Type: Article

References (29)

1. Adair B.M. Nanoparticle vaccines against respiratory viruses. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology 2009, 1:405-414.
2. Bamford A.I., Douglas A., Friede T., Stevanovic S., Rammensee H.G., Adair B.M. Peptide motif of a cattle mbc class-1 molecule. Immunology Letters 1995, 45:129-136.
3. Bennewitz N.L., Babensee J.E. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 2005, 26:2991-2999.
4. Bharali D.J., Pradhan V., Elkin G., Qi W., Hutson A., Mousa S.A., et al. Novel nanoparticles for the delivery of recombinant hepatitis B vaccine. Nanomedicine-Nanotechnology Biology and Medicine 2008, 4:311-317.
5. Borges O., Cordeiro-da-Silva A., Tavares J., Santarem N., de Sousa A., Borchard G., et al. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2008, 69:405-416.
6. Critchley H., Davis S.S., Farraj N.F., Illum L. Nasal absorption of desmopressin in rats and sheep - effect of a bioadhesive microsphere delivery system. Journal of Pharmacy and Pharmacology 1994, 46:651-656.
7. Fulton R.W. Bovine respiratory disease research (1983-2009). Animal Health Research Reviews 2009, 10(2):131-139.
8. Hans M.L., Lowman A.M. Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State & Materials Science 2002, 6:319-327.
9. Jeong I., Kim B.S., Lee H., Lee K.M., Shim I., Kang S.K., et al. Prolonged analgesic effect of PLGA-encapsulated bee venom on formalin-induced pain in rats. International Journal of Pharmaceutics 2009, 380:62-66.
10. Kalkanidis M., Pietersz G.A., Xiang S.D., Mottram P.L., Crimeen-Irwin B., Ardipradja K., et al. Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity. Methods (San Diego, Calif.) 2006, 40:20-29.
11. Kavanagh O.V., Earley B., Murray M., Foster C.J., Adair B.M. Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(DL-lactide-co-glycolide) microspheres. Vaccine 2003, 21:4472-4480.
12. Kim S.Y., Doh H.J., Jang M.H., Ha Y.J., Chung S.I., Park H.J. Oral immunization with Helicobacter pylori-loaded poly(D,L-lactide-co-glycolide) nanoparticles. Helicobacter 1999, 4:33-39.
13. Le Buanec H., Vetu C., Lachgar A., Benoit M.A., Gillard J., Paturance S., et al. Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes. Biomedicine & Pharmacotherapy 2001, 55:316-320.
14. Men Y., Audran R., Thomasin C., Eberl G., Demotz S., Merkle H.P., et al. MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine 1999, 17:1047-1056.
15. Mumford J.A., Jessett D., Dunleavy U., Wood J., Hannant D., Sundquist B., et al. Antigenicity and immunogenicity of experimental equine influenza iscom vaccines. Vaccine 1994, 12:857-863.
16. Nugent J., Po A.L.W., Scott E.M. Design and delivery of non-parenteral vaccines. Journal of Clinical Pharmacy and Therapeutics 1998, 23:257-285.
17. O'Hagan D.T., Jeffery H., Davis S.S. Long-term antibody-responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 1993, 11:965-969.
18. Pandey R., Ahmad Z., Sharma S., Khuller G.K. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery. International Journal of Pharmaceutics 2005, 301:268-276.
19. Peek L.J., Middaugh C.R., Berkland C. Nanotechnology in vaccine delivery. Advanced Drug Delivery Reviews 2008, 60:915-928.
20. Rabinovich N.R., McInnes P., Klein D.L., Hall B.F. Vaccine technologies - view to the future. Science 1994, 265:1401-1404.
21. Ray R., Novak M., Duncan J.D., Matsuoka Y., Compans R.W. Microencapsulated human parainfluenza virus induces a protective immune-response. Journal of Infectious Diseases 1993, 167:752-755.
22. Rebelatto M.C., Guimond P., Bowersock T.L., HogenEsch H. Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles. Veterinary Immunology and Immunopathology 2001, 83:93-105.
23. Roux X., Dubuquoy C., Durand G., Tran-Tolla T.L., Castagne N., Bernard J., et al. Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PLoS ONE 2008, 3:1-14.
24. Shephard M.J., Todd D., Adair B.M., Po A.L.W., Mackie D.P., Scott E.M. Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice. Research in Veterinary Science 2003, 74:187-190.
25. Sundquist B., Lovgren K., Morein B. Influenza-virus iscoms - antibody-response in animals. Vaccine 1988, 6:49-53.
26. Tang B.C., Dawson M., Lai S.K., Wang Y.Y., Suk J.S., Yang M., et al. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:19268-19273.
27. Vordermeier H.M., Pontarollo R., Karvonen B., Cockle P., Hecker R., Singh M., et al. Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c. Vaccine 2005, 23:4375-4384.
28. Walker K.B., Xing D.K.L., Sesardic D., Corbel M.J. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres. Symposium on Modulation of the Immune Response to Vaccine Antigens, Bergen, Norway 1996, pp; 259; 267.
29. Yoshida M., Babensee J.E. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. Journal of Biomedical Materials Research. Part A 2004, 71A:45-54.